ImpactLife has implemented a new non-invasive testing device called OrSense to measure a donor’s hemoglobin without drawing blood from the donor’s fingers, making the donation process ...

In a new documentary, four British professionals were pitted against an AI ‘clone' to find out how safe their job is ...

Ever wondered why some people avoid the doctor like the plague? A recent study shows a surprising number of Brits prefer to ...

To remedy its shortage, Luminis Health, the company that runs the Anne Arundel Medical Center in Annapolis, is offering free ...

This article was reviewed by Felix Gussone, MD. Low Testosterone and Joint Pain: What’s the Connection? Your knees, ankles, ...

Standard cancer screenings in the U.S. overlook nearly 70% of cancers and cancer subtypes. Multiple-cancer early detection (MCED) blood tests can help identify cancer biomarkers for multiple cancer ...

More than 240 million Americans have at least one risk factor for CKM syndrome, such as high blood pressure, abnormal ...

A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...

A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a ...

Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...

The company said its lab in San Marcos will take over testing that had been done in Austin. The layoffs will hit managers, ...